Beyond the Typical: Oral Agents for
Diabetic Retinopathy
COPE #105961-PH
Event #133385
Expiration Date: 7/24/2029
COURSE DESCRIPTION:
This course will consider inexpensive and readily available oral therapies for prevention and mitigation of diabetic retinopathy
LEARNING OBJECTIVES:
• Attendees will be able to describe current limitations of management strategies for diabetic retinopathy and macular edema
• Attendees will be able to specify what previously approved oral therapies have been shown to have benefit against diabetic retinal disease
• Attendees will be able to explain the evidence for nutritional strategies against DR/DME and practical recommendations for prevention
This presentation was recorded at the Victoria, BC Conference in July 2026.
The conference received unrestricted educational grant support from Alcon & Sun Pharma.
Write your awesome label here.
Video
Watch course online
Text material
Course slides for you to following along
Exam
Take and pass the exam with a 70% or higher
Certificate
Download CE Certificate
Getting to know our speakers
A. Paul Chous, MA, OD, FAAO
Dr. Chous emphasizes diabetes eye care and education. He is an Adjunct Professor of Optometry at Western University of Health Sciences, author of a book and more than 100 published papers on diabetes, a consultant to several eye care companies, and lectures both nationally and internationally at eye care conferences on diabetes, diabetic retinopathy, macular degeneration, and the role of nutrition in eye disease.
Dr. Chous is an editorial advisor to Review of Optometry and Optometry Times and has published clinical research in the prestigious British Journal of Ophthalmology. In 2017, he was named one of the 250 most influential optometrists in the United States.
Dr. Chous is an editorial advisor to Review of Optometry and Optometry Times and has published clinical research in the prestigious British Journal of Ophthalmology. In 2017, he was named one of the 250 most influential optometrists in the United States.